NO20091297L - Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet - Google Patents
Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighetInfo
- Publication number
- NO20091297L NO20091297L NO20091297A NO20091297A NO20091297L NO 20091297 L NO20091297 L NO 20091297L NO 20091297 A NO20091297 A NO 20091297A NO 20091297 A NO20091297 A NO 20091297A NO 20091297 L NO20091297 L NO 20091297L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- compatibility
- low
- corticosteroid
- pharmacologically active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84116406P | 2006-08-29 | 2006-08-29 | |
PCT/US2007/019164 WO2008027532A2 (en) | 2006-08-29 | 2007-08-29 | Pharmaceutical compositions including vitamin d and corticosteroid |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091297L true NO20091297L (no) | 2009-03-27 |
Family
ID=38880988
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091297A NO20091297L (no) | 2006-08-29 | 2009-03-27 | Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet |
Country Status (12)
Country | Link |
---|---|
US (3) | US20080064669A1 (ko) |
EP (1) | EP2056791A2 (ko) |
JP (1) | JP2010502624A (ko) |
KR (2) | KR20090039833A (ko) |
CN (1) | CN101505725A (ko) |
BR (1) | BRPI0715636A2 (ko) |
CA (1) | CA2670425A1 (ko) |
IL (1) | IL197107A0 (ko) |
MX (1) | MX2009002337A (ko) |
NO (1) | NO20091297L (ko) |
RU (1) | RU2452488C2 (ko) |
WO (1) | WO2008027532A2 (ko) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
US20060176966A1 (en) * | 2005-02-07 | 2006-08-10 | Stewart Kenneth A | Variable cyclic prefix in mixed-mode wireless communication systems |
US20100286101A1 (en) * | 2009-05-07 | 2010-11-11 | Jason Carbol | Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability |
US20110053898A1 (en) * | 2009-08-26 | 2011-03-03 | Glenmark Generics Ltd | Topical composition comprising vitamin d analogue and corticosteroids |
US8518917B2 (en) * | 2009-10-02 | 2013-08-27 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-vitamin D analogs and their uses |
JP5712010B2 (ja) * | 2010-03-24 | 2015-05-07 | 第一三共ヘルスケア株式会社 | ビタミンd類が安定化された化粧用又は医薬用外用組成物 |
US20140079785A1 (en) * | 2011-03-24 | 2014-03-20 | Leo Pharma A/S | Composition comprising lipid nanoparticles and a corticosteroid or vitamin d derivative |
CA2834301A1 (en) * | 2011-05-02 | 2012-11-08 | Lipidor Ab | Treatment of psoriasis |
JP2014523917A (ja) * | 2011-07-29 | 2014-09-18 | ベイジン ベータ ファーマシューティカルズ カンパニー, リミテッド | 低酸素模倣剤としての化合物の安定な多形体、およびその使用 |
US20170072321A1 (en) * | 2013-05-22 | 2017-03-16 | David S. Thompson | Highly interactive fantasy sports interleaver |
WO2017118885A1 (en) * | 2016-01-04 | 2017-07-13 | Gland Pharma Limited | Stable pharmacuetical compositions of calcitriol |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
CN108815174A (zh) * | 2018-05-25 | 2018-11-16 | 昆山普瑞凯纳米技术有限公司 | 一种改良型脂溶性组合物及其制备方法 |
US20210196631A1 (en) * | 2018-08-28 | 2021-07-01 | Glenmark Pharmaceuticals Limited | Container system and pharmaceutical foam composition comprising betamethasone |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4610978A (en) * | 1983-03-22 | 1986-09-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
US4594340A (en) * | 1984-11-29 | 1986-06-10 | Hoffmann-La Roche Inc. | 25,26-dehydro-1α,24R-dihydroxycholecalciferol and 25,26-dehydro-1α,24S-dihydroxycholecalciferol and the epimeric mixture |
DE3666587D1 (en) * | 1985-08-02 | 1989-11-30 | Leo Pharm Prod Ltd | Novel vitamin d analogues |
US5401731A (en) * | 1989-06-29 | 1995-03-28 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) | Vitamin D analogues |
US5824313A (en) * | 1989-09-25 | 1998-10-20 | University Of Utah Research Foundation | Vaccine compositions and method for induction of mucosal immune response via systemic vaccination |
DE3933034A1 (de) * | 1989-10-02 | 1991-04-11 | Schering Ag | 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung |
GB9004544D0 (en) * | 1990-03-01 | 1990-04-25 | Leo Pharm Prod Ltd | Novel treatment ii |
GB9017890D0 (en) * | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
US5789397A (en) * | 1991-01-08 | 1998-08-04 | Bone Care International, Inc. | Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2 |
IL99368A (en) * | 1991-09-02 | 1996-01-19 | Teva Pharma | Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine |
GB9226860D0 (en) * | 1992-12-23 | 1993-02-17 | Leo Pharm Prod Ltd | Novel treatment |
GB9300763D0 (en) * | 1993-01-15 | 1993-03-03 | Leo Pharm Prod Ltd | Chemical compound |
US6103709A (en) * | 1993-12-23 | 2000-08-15 | The Regents Of The University Of California | Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases |
ES2144239T3 (es) * | 1995-06-14 | 2000-06-01 | Schering Ag | Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos. |
JPH11514999A (ja) * | 1995-10-10 | 1999-12-21 | ストルーブ,マリリン | ビタミンdおよびその誘導体による掻痒症治療 |
WO1997018817A1 (fr) * | 1995-11-20 | 1997-05-29 | Kiyoshi Kita | Preparation externe contenant de la vitamine d ou de la vitamine k |
GB9524812D0 (en) * | 1995-12-05 | 1996-02-07 | Leo Pharm Prod Ltd | Chemical compounds |
GB9611603D0 (en) * | 1996-06-04 | 1996-08-07 | Leo Pharm Prod Ltd | Chemical compounds |
TWI247001B (en) * | 1996-07-01 | 2006-01-11 | Chugai Pharmaceutical Co Ltd | The method for purifying vitamin d derivatives and its crystalline products |
GB9622590D0 (en) * | 1996-10-30 | 1997-01-08 | Leo Pharm Prod Ltd | Chemical compounds |
JP2002506429A (ja) * | 1997-05-16 | 2002-02-26 | ウィメン アンド インファンツ ホスピタル | 3−エピビタミンd2化合物及びその使用法 |
US6599513B2 (en) * | 1997-05-27 | 2003-07-29 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
US6372234B1 (en) * | 1997-05-27 | 2002-04-16 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
US6187331B1 (en) * | 1997-06-10 | 2001-02-13 | New Vision Co., Ltd. | Composition for prophylaxis and/or treatment of dry syndrome comprising vitamin D |
GB9721156D0 (en) * | 1997-10-06 | 1997-12-03 | Leo Pharm Prod Ltd | Novel vitamin d analogues |
US6531459B1 (en) * | 1997-12-17 | 2003-03-11 | Schering Aktiengesellschaft | Vitamin D derivatives with phosphorus atoms in the side chains |
US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
JP2000064450A (ja) * | 1998-08-21 | 2000-02-29 | Kikkona Kk | 断熱性に優れたパネル材および断熱性に優れたパネル構造体 |
PT3146969T (pt) * | 1999-04-23 | 2018-10-18 | Leo Pharma As | Composição farmacêutica para aplicação dérmica para uso no tratamento da psoríase compreendendo vitamina d e um corticosteroide |
DE19935771A1 (de) * | 1999-07-23 | 2001-02-01 | Schering Ag | Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
CN100382803C (zh) * | 2000-10-27 | 2008-04-23 | 里奥制药有限公司 | 含有至少一种维生素d或一种维生素d类似物和至少一种皮质类固醇的局部组合物 |
WO2003087048A2 (en) * | 2002-04-11 | 2003-10-23 | Instytut Farmaceutyczny | Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds |
WO2005074389A2 (ja) * | 2004-02-03 | 2005-08-18 | Chugai Pharmaceutical Co Ltd | ビタミンd化合物及びそれらの合成中間体の合成方法 |
BRPI0511389A (pt) * | 2004-06-17 | 2007-12-04 | Galderma Sa | composição e seu uso |
DK1771180T4 (da) * | 2004-06-17 | 2011-04-11 | Galderma Sa | Sammensætning i form af en spray, der omfatter en kombination af clobetasolpropionat og calcitriol, en alkoholfase og en oliefase |
FR2871694B1 (fr) * | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises |
FR2871700B1 (fr) * | 2004-06-17 | 2006-11-17 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse |
FR2871699A1 (fr) * | 2004-06-17 | 2005-12-23 | Galderma Sa | Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie |
FR2871696B1 (fr) * | 2004-06-17 | 2006-11-10 | Galderma Sa | Composition topique pour le traitement du psoriasis |
FR2871697B1 (fr) * | 2004-06-17 | 2007-06-29 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile |
US20100056644A1 (en) * | 2006-11-29 | 2010-03-04 | Nilendu Sen | Pharmaceutical compositions containing anhydrous calcipotriene |
-
2007
- 2007-08-29 JP JP2009526737A patent/JP2010502624A/ja active Pending
- 2007-08-29 EP EP07811641A patent/EP2056791A2/en not_active Withdrawn
- 2007-08-29 WO PCT/US2007/019164 patent/WO2008027532A2/en active Application Filing
- 2007-08-29 MX MX2009002337A patent/MX2009002337A/es unknown
- 2007-08-29 BR BRPI0715636-7A patent/BRPI0715636A2/pt not_active IP Right Cessation
- 2007-08-29 KR KR1020097004890A patent/KR20090039833A/ko not_active Application Discontinuation
- 2007-08-29 US US11/897,540 patent/US20080064669A1/en not_active Abandoned
- 2007-08-29 RU RU2009109164/15A patent/RU2452488C2/ru not_active IP Right Cessation
- 2007-08-29 KR KR1020117022443A patent/KR20110113664A/ko not_active Application Discontinuation
- 2007-08-29 CN CNA2007800316568A patent/CN101505725A/zh active Pending
- 2007-08-29 CA CA002670425A patent/CA2670425A1/en not_active Abandoned
-
2009
- 2009-02-18 IL IL197107A patent/IL197107A0/en unknown
- 2009-03-27 NO NO20091297A patent/NO20091297L/no not_active Application Discontinuation
-
2011
- 2011-10-12 US US13/271,890 patent/US20120028934A1/en not_active Abandoned
- 2011-10-27 US US13/283,071 patent/US20120046253A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
RU2452488C2 (ru) | 2012-06-10 |
US20120028934A1 (en) | 2012-02-02 |
KR20110113664A (ko) | 2011-10-17 |
MX2009002337A (es) | 2009-03-20 |
US20120046253A1 (en) | 2012-02-23 |
CA2670425A1 (en) | 2008-03-06 |
EP2056791A2 (en) | 2009-05-13 |
KR20090039833A (ko) | 2009-04-22 |
WO2008027532A3 (en) | 2008-04-17 |
WO2008027532A2 (en) | 2008-03-06 |
CN101505725A (zh) | 2009-08-12 |
IL197107A0 (en) | 2009-11-18 |
BRPI0715636A2 (pt) | 2013-07-02 |
JP2010502624A (ja) | 2010-01-28 |
RU2009109164A (ru) | 2010-10-10 |
US20080064669A1 (en) | 2008-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20091297L (no) | Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet | |
NO20073959L (no) | Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller | |
NO20092723L (no) | Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer | |
BRPI0821004A8 (pt) | Composto derivado de aminopirazol, composição farmacêutica que o contem e uso deste | |
WO2010093727A8 (en) | Quinazolinones as prolyl hydroxylase inhibitors | |
BRPI0513184A (pt) | derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia | |
BRPI0517792A (pt) | macrolonas - quinolonas amino-substituìdas | |
NO20071617L (no) | Indozolonderivater som 11B-HSD1-inhibitorer | |
WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
AR047993A1 (es) | Composicion farmaceutica que comprende pimobendano | |
AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
UA95199C2 (en) | Aqueous formulation of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid | |
NO20082730L (no) | Morfolinopyrimidinderivater og deres anvendelse i terapi | |
NO20080408L (no) | Azaindazolforbindelser og anvendelse derav | |
MX2009001711A (es) | Formulaciones de liberacion sostenida de topiramato. | |
PL1940249T3 (pl) | Nowe formulacje rozpuszczalnych w tłuszczach składników aktywnych o wysokiej biodostępności | |
WO2007135527A3 (en) | Benzimidazolyl compounds | |
TW200745136A (en) | 4-Amino-thieno[3,2-c]pyridine-7-carboxylic acid derivatives | |
NO20090346L (no) | Pyrazolderivater som inhibitorer av cytokrom P450 | |
EA201000436A1 (ru) | Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью | |
EP2142549A4 (en) | ADENOSINE DERIVATIVES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF INFLAMMATORY DISEASES THEREOF CONTAINING THEM AS AN ACTIVE SUBSTANCE | |
UY28979A1 (es) | Derivados de hidrocloruros de 3-carboxamida, composiciones farmacéuticas que los contienen, procedimiento de preparación y su uso, útiles como inhibidores selectivos de gsk3 | |
WO2008012338A3 (en) | Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions | |
PA8566601A1 (es) | Derivados de nicotinamida utiles como inhibidores de pde4 | |
ES2328496T3 (es) | Compuestos de 1,4,8-triaza-espiro(4,5)decan-2-ona sustituidos. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |